Merck (MRK) rallies after FDA drug approval. Kevin Green discusses this as Merck receives FDA approval for drug Winrevair to treat pulmonary arterial hypertension. Green also goes over how Moderna (MRNA) is trading higher after a $750M investment in flu research. Tune in to find out more about the stock market today.